Showing results (291-300 of 809) with videos related to
Sort By:
Pageof 81
Arteriosclerosis, Thrombosis, and Vascular Biology|July 7, 2007
Wild-type ApoA-I and the Milano variant have similar abilities to stimulate cellular lipid mobilization and effluxGinny L Weibel, Eric T Alexander, Michelle R Joshi, et al.Circulation. Genomic and Precision Medicine|July 11, 2018
Multiplexed Targeted Resequencing Identifies Coding and Regulatory Variation Underlying Phenotypic Extremes of High-Density Lipoprotein Cholesterol in HumansSumeet A Khetarpal, Paul L Babb, Wei Zhao, et al.Journal of Lipid Research|August 5, 2018
Directional ABCA1-mediated cholesterol efflux and apoB-lipoprotein secretion in the retinal pigment epitheliumNicholas N Lyssenko, Naqi Haider, Antonino Picataggi, et al.Atherosclerosis|September 19, 2016
A phase III randomized trial evaluating alirocumab 300 mg every 4 weeks as monotherapy or add-on to statin: ODYSSEY CHOICE IEli M Roth, Patrick M Moriarty, Jean Bergeron, et al.The Journal of Clinical Investigation|July 28, 2007
Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivoXun Wang, Heidi L Collins, Mollie Ranalletta, et al.The Journal of Pediatrics|May 25, 2012
Prediabetic obese adolescents have a more atherogenic lipoprotein profile compared with normoglycemic obese peersSheela N Magge, Divya Prasad, Dorit Koren, et al.Journal of Neurochemistry|June 15, 2005
Regulated expression of endothelial lipase by porcine brain capillary endothelial cells constituting the blood-brain barrierAndrea Sovic, Ute Panzenboeck, Andrea Wintersperger, et al.Cardiovascular Drugs and Therapy|September 14, 2016
Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/dl or HigherHenry N Ginsberg, Daniel J Rader, Frederick J Raal, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|December 17, 2005
Effects of rosiglitazone on lipids, adipokines, and inflammatory markers in nondiabetic patients with low high-density lipoprotein cholesterol and metabolic syndromeFrederick F Samaha, Philippe O Szapary, Nayyar Iqbal, et al.Atherosclerosis|February 18, 2014
Genetic manipulation of the ApoF/Stat2 locus supports an important role for type I interferon signaling in atherosclerosisWilliam R Lagor, David W Fields, Robert C Bauer, et al.Pageof 81